Interaction ID
ncRI-40646930
Interaction Molecules
hsa-miR-513a-3p -- YAP1
Interaction Level
RNA-RNA
Interaction Class
binding
Data Source
miRanda with Ago CLIP data
Tags
Organism
Homo sapiens
Tissue or Cell Type
T-REx-293T
Experiment
AGO CLIP
Description
Conserved miRNAs target sites predicted by miRanda overlap with the AGO CLIP dataset
Alias
-
Class
mRNA
Ensembl id
ENSG00000137693
Description
Transcriptional regulator which can act both as a coactivator and a corepressor and is the critical downstream regulatory target in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis (PubMed:17974916, PubMed:18280240, PubMed:18579750, PubMed:21364637, PubMed:30447097). The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ (PubMed:18158288). Plays a key role in tissue tension and 3D tissue shape by regulating cortical actomyosin network formation. Acts via ARHGAP18, a Rho GTPase activating protein that suppresses F-actin polymerization (PubMed:25778702). Plays a key role to control cell proliferation in response to cell contact. Phosphorylation of YAP1 by LATS1/2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration (PubMed:18158288). The presence of TEAD transcription factors are required for it to stimulate gene expression, cell growth, anchorage-independent growth, and epithelial mesenchymal transition (EMT) induction (PubMed:18579750).
Pubmed ID | 29273203 | Journal | Journal of molecular biology |
---|---|---|---|
Title | Transcriptome-wide Identification and Validation of Interactions between the miRNA Machinery and HuR on mRNA Targets. | ||
Author | Li Y, Estep JA, Karginov FV |
Molecule | Disease | Data Source |
---|---|---|
hsa-miR-513a-3p | adrenocortical carcinoma | MNDR Database |
hsa-miR-513a-3p | Adrenocortical Carcinoma | MNDR Database |
hsa-miR-513a-3p | Alzheimer's disease | MNDR Database |
hsa-miR-513a-3p | arthritis | MNDR Database |
hsa-miR-513a-3p | asthma | MNDR Database |
hsa-miR-513a-3p | autosomal recessive disease | MNDR Database |
hsa-miR-513a-3p | B-cell lymphoma | MNDR Database |
hsa-miR-513a-3p | biliary tract cancer | MNDR Database |
hsa-miR-513a-3p | bone disease | MNDR Database |
hsa-miR-513a-3p | brain disease | MNDR Database |
hsa-miR-513a-3p | breast cancer | MNDR Database |
hsa-miR-513a-3p | Breast Neoplasms | MNDR Database |
hsa-miR-513a-3p | cancer | MNDR Database |
hsa-miR-513a-3p | carcinoma | MNDR Database |
hsa-miR-513a-3p | cholangiocarcinoma | MNDR Database |
hsa-miR-513a-3p | colon cancer | MNDR Database |
hsa-miR-513a-3p | colorectal cancer | MNDR Database |
hsa-miR-513a-3p | diabetes mellitus | MNDR Database |
hsa-miR-513a-3p | Down syndrome | MNDR Database |
hsa-miR-513a-3p | esophageal cancer | MNDR Database |
hsa-miR-513a-3p | eye disease | MNDR Database |
hsa-miR-513a-3p | familiar ovarian carcinoma | MNDR Database |
hsa-miR-513a-3p | heart disease | MNDR Database |
hsa-miR-513a-3p | hepatocellular carcinoma | MNDR Database |
hsa-miR-513a-3p | Her2-receptor positive breast cancer | MNDR Database |
hsa-miR-513a-3p | Hodgkin's lymphoma | MNDR Database |
hsa-miR-513a-3p | hypersensitivity reaction type II disease | MNDR Database |
hsa-miR-513a-3p | intellectual disability | MNDR Database |
hsa-miR-513a-3p | intrahepatic cholangiocarcinoma | MNDR Database |
hsa-miR-513a-3p | kidney disease | MNDR Database |
hsa-miR-513a-3p | leukemia | MNDR Database |
hsa-miR-513a-3p | liposarcoma | MNDR Database |
hsa-miR-513a-3p | liver cirrhosis | MNDR Database |
hsa-miR-513a-3p | Liver Neoplasms | MNDR Database |
hsa-miR-513a-3p | lung adenocarcinoma | MNDR Database |
hsa-miR-513a-3p | lung cancer | MNDR Database |
hsa-miR-513a-3p | lung disease | MNDR Database |
hsa-miR-513a-3p | lung squamous cell carcinoma | MNDR Database |
hsa-miR-513a-3p | lupus nephritis | MNDR Database |
hsa-miR-513a-3p | lymphoma | MNDR Database |
hsa-miR-513a-3p | male infertility | MNDR Database |
hsa-miR-513a-3p | malignant glioma | MNDR Database |
hsa-miR-513a-3p | melanoma | MNDR Database |
hsa-miR-513a-3p | multiple myeloma | MNDR Database |
hsa-miR-513a-3p | nephroblastoma | MNDR Database |
hsa-miR-513a-3p | neurodegenerative disease | MNDR Database |
hsa-miR-513a-3p | non-Hodgkin lymphoma | MNDR Database |
hsa-miR-513a-3p | oral squamous cell carcinoma | MNDR Database |
hsa-miR-513a-3p | osteosarcoma | MNDR Database |
hsa-miR-513a-3p | ovarian clear cell carcinoma | MNDR Database |
hsa-miR-513a-3p | Ovarian Neoplasms | MNDR Database |
hsa-miR-513a-3p | pancreatic adenocarcinoma | MNDR Database |
hsa-miR-513a-3p | pancreatic cancer | MNDR Database |
hsa-miR-513a-3p | pancreatic ductal adenocarcinoma | MNDR Database |
hsa-miR-513a-3p | pituitary adenoma | MNDR Database |
hsa-miR-513a-3p | progesterone-receptor negative breast cancer | MNDR Database |
hsa-miR-513a-3p | progesterone-receptor positive breast cancer | MNDR Database |
hsa-miR-513a-3p | Prostatic Neoplasms | MNDR Database |
hsa-miR-513a-3p | retinoblastoma | MNDR Database |
hsa-miR-513a-3p | schizophrenia | MNDR Database |
hsa-miR-513a-3p | skin disease | MNDR Database |
hsa-miR-513a-3p | skin melanoma | MNDR Database |
hsa-miR-513a-3p | stomach cancer | MNDR Database |
hsa-miR-513a-3p | Stroke, Lacunar | MNDR Database |
hsa-miR-513a-3p | tonsil cancer | MNDR Database |
hsa-miR-513a-3p | urinary bladder cancer | MNDR Database |
hsa-miR-513a-3p | vascular disease | MNDR Database |
hsa-miR-513a-3p | coloboma, ocular, autosomal dominant | eDGAR Database |
hsa-miR-513a-3p | coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation | eDGAR Database |